Matches in Nanopublications for { ?s ?p "[LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP244563.RA32lwhEjylVHgjM0LhSQT4QdsZYMee3xS2rfOdPqYpuU130_assertion description "[LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP244563.RA32lwhEjylVHgjM0LhSQT4QdsZYMee3xS2rfOdPqYpuU130_provenance.
- NP532921.RASTJfgcqgUEEEGFWU8FLcTEMdHohcU0c8O7u6uc6ftQE130_assertion description "[LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP532921.RASTJfgcqgUEEEGFWU8FLcTEMdHohcU0c8O7u6uc6ftQE130_provenance.
- NP539453.RAck8dQ1c5ztKdPn_hnq1VFioVjCfBQTdZXwp8GIin4Bw130_assertion description "[LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539453.RAck8dQ1c5ztKdPn_hnq1VFioVjCfBQTdZXwp8GIin4Bw130_provenance.
- assertion description "[LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP952438.RAeFz2l58nDuvKp74G9DWkxj80KP2XqgaEbN8AAZXug_0130_assertion description "[LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952438.RAeFz2l58nDuvKp74G9DWkxj80KP2XqgaEbN8AAZXug_0130_provenance.
- NP952433.RAp7V4z4XVCUArGBiyuRWREPkxioAqBi-V5BVB08-wjsw130_assertion description "[LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952433.RAp7V4z4XVCUArGBiyuRWREPkxioAqBi-V5BVB08-wjsw130_provenance.
- NP952435.RAm7Jm5OalZCPT9Y0sSbkCWk0H5FSylzYPd80GEkovYdU130_assertion description "[LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952435.RAm7Jm5OalZCPT9Y0sSbkCWk0H5FSylzYPd80GEkovYdU130_provenance.